alpha-Glucosidases: Clinical Trials

1 trial of alpha-Glucosidases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow alpha-Glucosidases: new trials by email Literature Review of alpha-Glucosidases trials Research Report on alpha-Glucosidases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
AB-1009 (GAA Gene) - Pompe Disease (Late-onset), Pompe Disease Late-Onset
Phase 1 / Phase 2RecruitingAskBio Inc122026-04-152026-10-13

Conditions studied

Glycogen Storage Disease (1)  ·  Glycogen Storage Disease Type II (1)  ·  Lysosomal Storage Diseases (1)  ·  Neuromuscular Diseases (1)

Sponsors

AskBio Inc (1)

Countries

United States (1)